Silver Book Fact

Reducing risk of fracture from 8% to 2% reduces the 5-year fracture incidence from approximately 34% to 10%.

Lindsay R, Pack S, Li Z. Longitudinal Progression of Fracture Prevalence through a Population of Postmenopausal Women with Osteoporosis. Osteoporos Int. 2005; 16(3): 306-12. http://www.ncbi.nlm.nih.gov/pubmed/15455193

Reference

Title
Longitudinal Progression of Fracture Prevalence through a Population of Postmenopausal Women with Osteoporosis
Publication
Osteoporos Int
Publication Date
2005
Authors
Lindsay R, Pack S, Li Z
Volume & Issue
Volume 16, Issue 3
Pages
306-12
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Risedronate, a bisphosphonate, has been shown to reduce vertebral fractures by around 41%, hip fractures by 30%, and non-vertebral fractures by 39%.  
  • A recent study found that more postmenopausal women who took the drug denosumab gained at least 3% of bone mass at the hip and spine than those who took…  
  • A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.  
  • Patients with vertebral fractures who underwent kyphoplasty, a procedure that stabilizes fractures of the spine, were found in one study to have reduced pain, fewer new fractures, and less healthcare…  
  • Treatment with bisphosphonates are highly cost-effective in women over the age of 70 with osteoporosis and a previous fracture.